reAlpha Tech Corp. Faces Nasdaq Non-Compliance Following Two Director Resignations

summarizeSummary

reAlpha Tech Corp. reported the resignation of two directors, leading to non-compliance with Nasdaq's audit committee requirements and initiating a cure period to avoid potential delisting.

check_boxKey Events

• Two Directors Resign

  Brian Cole and Monaz Karkaria resigned from the Board of Directors and all committees, effective February 4 and February 5, 2026, respectively. The company stated these resignations were not due to disagreements.

• Nasdaq Non-Compliance

  Brian Cole's resignation created a vacancy on the Audit Committee, resulting in the company's non-compliance with Nasdaq Listing Rule 5605(c)(2)(A), which requires a three-member audit committee.

• Initiation of Cure Period

  The company notified Nasdaq of its non-compliance on February 6, 2026, and intends to rely on the provided cure period to appoint a third director to the Audit Committee by its next annual meeting or within 180 days.

auto_awesomeAnalysis

reAlpha Tech Corp. disclosed the resignation of two directors, Brian Cole and Monaz Karkaria, from its Board and all committees. Critically, Brian Cole's departure created a vacancy on the Audit Committee, leading to the company's non-compliance with Nasdaq's requirement for a three-member audit committee. While the company has a cure period to appoint a new director, this situation highlights significant governance challenges and poses a risk to its Nasdaq listing if not resolved promptly. Investors should monitor the company's progress in appointing a qualified director to regain compliance.